Literature DB >> 11527261

Diagnostic value of preoperative RT-PCR-based screening method to detect carcinoembryonic antigen-expressing free cancer cells in the peritoneal cavity from patients with gastric cancer.

Y Yonemura1, Y Endou, T Fujimura, S Fushida, E Bandou, K Kinoshita, K Sugiyama, T Sawa, B S Kim, T Sasaki.   

Abstract

BACKGROUND: At present the most reliable method for the diagnosis of peritoneal micrometastasis of gastric cancer is peritoneal wash cytology, but the sensitivity of this method is low. The aim of the present study was to verify whether carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) assay can enhance the sensitivity and specificity of conventional cytology, and to determine how this technique can improve the accuracy of peritoneal recurrence.
METHODS: The present study included 230 patients with gastric cancer. Preoperative peritoneal wash was done by a paracentesis, followed by conventional cytology, CEA measurement, and CEA RT-PCR of recovered fluid.
RESULTS: The CEA RT-PCR assay yielded 40 (17%) positives, which included none of the 26 patients with benign disease. The incidence of positive cytology and CEA level in wash fluid was 19% and 15%, respectively. Logistic stepwise regression analysis revealed that lymph node status, depth of invasion, venous invasion, and the results of peritoneal cytological examination, and CEA RT-PCR assay were independently related to peritoneal recurrence. The CEA level in the wash fluid was not related to peritoneal recurrence. Peritoneal cytological examination was the most significant predictive factor for peritoneal recurrence with a sensitivity of 46%, specificity of 94% and accuracy of 73%, while the corresponding values of the CEA RT-PCR assay were 31%, 95%, and 73%. Combining cytological examination with CEA RT-PCR assay resulted in a sensitivity rate for peritoneal recurrence of 57%, an 11% improvement over that of cytology alone.
CONCLUSION: The data indicate that the use of a combination of CEA RT-PCR and cytological assay is more likely to identify patients who will develop peritoneal recurrence. This may be useful for the classification of patients for the most suitable therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527261     DOI: 10.1046/j.1440-1622.2001.02187.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  16 in total

Review 1.  New approaches to gastric cancer staging: beyond endoscopic ultrasound, computed tomography and positron emission tomography.

Authors:  Hyuk Yoon; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

2.  Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance.

Authors:  Joyce Wong; Kaitlyn Jane Kelly; Arjun Mittra; Mithat Gonen; Peter Allen; Yuman Fong; Daniel Coit
Journal:  J Gastrointest Surg       Date:  2012-02-24       Impact factor: 3.452

Review 3.  Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer.

Authors:  Zhong-He Ji; Kai-Wen Peng; Yan Li
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-19

Review 4.  Role of genetic detection in peritoneal washes with gastric carcinoma: The past, present and future.

Authors:  Hyun-Dong Chae
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

5.  Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.

Authors:  Zhen Li; Dewei Zhang; Hao Zhang; Zhifeng Miao; Yuanxin Tang; Gongping Sun; Dongqiu Dai
Journal:  Tumour Biol       Date:  2013-11-27

6.  Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.

Authors:  Kaitlyn J Kelly; Joyce Wong; Rebecca Gladdy; Kimberly Moore-Dalal; Yanghee Woo; Mithat Gonen; Murray Brennan; Peter Allen; Yuman Fong; Daniel Coit
Journal:  Ann Surg Oncol       Date:  2009-09-18       Impact factor: 5.344

Review 7.  Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives.

Authors:  Yoshiyuki Fujiwara; Yuichiro Doki; Hirokazu Taniguchi; Itsuro Sohma; Shuji Takiguchi; Hiroshi Miyata; Makoto Yamasaki; Morito Monden
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

8.  Detection of carcinoembryonic antigen mRNA in peritoneal washes from gastric cancer patients and its clinical significance.

Authors:  Yan-Song Zhang; Jun Xu; Guang-Hua Luo; Rong-Chao Wang; Jiang Zhu; Xiao-Ying Zhang; Peter Nilsson-Ehle; Ning Xu
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 9.  Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis.

Authors:  Y Xiao; J Zhang; X He; J Ji; G Wang
Journal:  Ir J Med Sci       Date:  2013-12-31       Impact factor: 1.568

10.  Diagnostic value of negative enrichment and immune fluorescence in situ hybridization for intraperitoneal free cancer cells of gastric cancer.

Authors:  Anqiang Wang; Zhongwu Li; Qian Wang; Yali Bai; Xin Ji; Tao Fu; Ke Ji; Yanwen Xue; Tingxu Han; Xiaojiang Wu; Ji Zhang; Yingjie Yang; Guobin Xu; Zhaode Bu; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.